[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nuvalent Cl A (NUVL)

Nuvalent Cl A (NUVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVL

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Nuvalent, Inc ...

NUVL : 123.96 (+0.02%)
GSK : 50.74 (-0.04%)
Are NUVL, ROKU, PAYO, HUN Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

HUN : 12.81 (-3.10%)
ROKU : 141.67 (-0.99%)
PAYO : 7.12 (unch)
NUVL : 123.96 (+0.02%)
Are NUVL, CPRX, TMHC Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

TMHC : 72.45 (-0.03%)
NUVL : 123.96 (+0.02%)
CPRX : 31.49 (+0.03%)
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TMHC, NUVL, AXTA, and PFLC

NEW YORK , June 24, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars...

TMHC : 72.45 (-0.03%)
PFLC : 17.7000 (-2.21%)
NUVL : 123.96 (+0.02%)
AXTA : 31.68 (-3.41%)
Are ROKU, SLP, NUVL, DAN Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

DAN : 27.63 (-1.46%)
ROKU : 141.67 (-0.99%)
SLP : 18.33 (+0.44%)
NUVL : 123.96 (+0.02%)
Are NUVL, DAN, PAYO Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

DAN : 27.63 (-1.46%)
PAYO : 7.12 (unch)
NUVL : 123.96 (+0.02%)
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SUNE, NUVL, CCRN, and BGMS

NEW YORK , June 17, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for...

CCRN : 13.25 (+0.08%)
BGMS : 0.8751 (-2.23%)
NUVL : 123.96 (+0.02%)
SUNE : 2.60 (+10.17%)
MarketBeat Week in Review – 06/08 - 06/12

Stocks rallied on optimism surrounding a potential U.S.-Iran peace deal and SpaceX's historic IPO debut, reinforcing investor confidence and market momentum

NVDA : 208.76 (-1.56%)
GOOGL : 317.69 (-7.13%)
AAPL : 321.66 (-1.30%)
WING : 134.86 (-2.36%)
SPOT : 468.99 (-1.09%)
CBRL : 51.82 (-2.54%)
P : 75.19 (+0.82%)
IREN : 40.58 (-1.70%)
TSLA : 319.69 (-14.52%)
SPCX : 118.24 (+2.59%)
INTC : 100.23 (-2.33%)
NUVL : 123.96 (+0.02%)
Are AVNS, NUVL, XOMA, TBRG Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

XOMA : 40.17 (-9.16%)
TBRG : 26.24 (unch)
AVNS : 24.98 (unch)
NUVL : 123.96 (+0.02%)
Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion

GSK agreed to acquire Nuvalent for $10.6 billion, or $124 per share, a roughly 40% premium, to add two late-stage lung cancer assets and offset an impending patent cliff.

RHHVF : 428.0540 (+5.18%)
NUVL : 123.96 (+0.02%)
GSK : 50.74 (-0.04%)
PFE : 25.01 (+0.77%)

Barchart Exclusives

The Trump Administration Just Gave X-Energy Stock a Boost. Wall Street Sees 137% Upside Ahead.
Government backing boosted X-Energy's AI nuclear story, while analysts continue to see substantial long-term upside despite execution risks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.